SM, A., KA, S., CJ, D., CJ, H., D, T., J, H., . . . DY, K. (2011). Phase I dose escalation safety study of nanoparticulate paclitaxel (CTI 52010) in normal dogs. Dove Medical Press.
Cita Chicago Style (17a ed.)SM, Axiak, Selting KA, Decedue CJ, Henry CJ, Tate D, Howell J, Bilof KJ, y Kim DY. Phase I Dose Escalation Safety Study of Nanoparticulate Paclitaxel (CTI 52010) in Normal Dogs. Dove Medical Press, 2011.
Cita MLA (8a ed.)SM, Axiak, et al. Phase I Dose Escalation Safety Study of Nanoparticulate Paclitaxel (CTI 52010) in Normal Dogs. Dove Medical Press, 2011.
Precaución: Estas citas no son 100% exactas.